Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06456372 · ClinicalTrials.gov registry record · NA

Digital Health Intervention for Children With ADHD

A NA study of ADHD, sponsored by University of California, Riverside.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
2
Study locations

NCT06456372: Recruiting NA study of ADHD, sponsored by University of California, Riverside.

NCT06456372 is a NA study of ADHD that is actively recruiting participants, run by University of California, Riverside. The registered enrollment target is 60 participants, below the 189-participant average among 75 other ADHD trials with a reported enrollment target (68% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06456372, a NA study of ADHD, is actively recruiting participants, sponsored by University of California, Riverside.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
2
Study locations

Study Summary

To conduct an RCT to evaluate the efficacy of the system, we will recruit 60 children (ages 8-12) with ADHD who will be randomized to either immediate (n=30) or delayed (n=30) treatment (i.e., a wait-list control group). Among those randomized to immediate treatment, half will be assigned to DHI (delivered via a smartwatch and smartphone application) and half will be assigned to an active control treatment as usual (TAU) group who will receive the smartwatch with no assigned activities, applications, or interventions on the devices. The intervention period will last 16 weeks; after a participant has been in the delayed treatment group for 16 weeks and has completed the post-waiting period assessment, he or she will be assigned to either the intervention or active control group. Thus, 30 participants will complete the intervention and 30 will complete the active control, with half of the total sample also completing a wait-list period.

Primary Outcome

Behavior Assessment System for Children - BASC-3 Self, Parent, and Teacher reports - The Behavior Assessment System for Children - Third Edition is an individually-administered, norm-referenced, comprehensive set of rating scales and forms designed to inform understanding of the behaviors and emotions of children and adolescents ages 2 years through 21 years, 11 months. Forms available in this system include Parent Rating Scales (PRS), Teacher Rating Scales (TRS), the Self-Report of Personality

Conditions Studied

Interventions

  • BEHAVIORAL Digital Health Intervention Group

Study Locations (2)

California

  • The Craig School - Irvine
  • UCR Psychiatry at Grindstaff Community School - Riverside

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2025-02-22
Est. Completion 2027-09-29
Phase NA

What NCT06456372 shows while recruiting

NCT06456372 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 189-participant average among 75 other ADHD trials with a reported enrollment target (68% lower).

The record links to 1 condition, with ADHD appearing as the primary indexed condition, and to 1 intervention - of which Digital Health Intervention Group is the first listed.

NCT06456372 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06456372 about?

NCT06456372 is a clinical study titled "Digital Health Intervention for Children With ADHD". To conduct an RCT to evaluate the efficacy of the system, we will recruit 60 children (ages 8-12) with ADHD who will be randomized to either immediate (n=30) or delayed (n=30) treatment (i.e., a wait-list control group). Among those randomized to immediate treatment, half will be assigned to DHI (de...

What is the current status of trial NCT06456372?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-02-22. Estimated completion is 2027-09-29.

What conditions does trial NCT06456372 study?

This clinical trial studies the following conditions: ADHD.

What interventions are being tested in trial NCT06456372?

The interventions under investigation include: Digital Health Intervention Group (BEHAVIORAL).

Who is sponsoring clinical trial NCT06456372?

This trial is sponsored by University of California, Riverside, which has 10 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06456372 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for ADHD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06456372's enrollment target sits among peer trials

60 42nd of 75 higher than 34 of 75 other ADHD trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other ADHD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06456372, the US trial registry maintained by the National Library of Medicine. NCT06456372 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.